Reduced intravenous toxicity of amiodarone nanosuspension in mice and rats

Drug and Chemical Toxicology

Volumn 36, Issue 3, 2013, Pages 263-269

  Barle, Ester Lovšin ^a   Černe, Manica ^a   Peternel, Luka ^a   Homar, Miha ^a  

^a Lek dd   (Slovenia)

Author keywords

Amiodarone; Nanosuspension; Toxicity

Indexed keywords

AMIODARONE; EXCIPIENT;

ACUTE TOXICITY; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; DRUG SOLUBILITY; FEMALE; LD 50; MOUSE; NONHUMAN; PARTICLE SIZE; RAT; SUSPENSION;

AMIODARONE; ANIMALS; ANTI-ARRHYTHMIA AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCIPIENTS; FEMALE; INJECTIONS, INTRAVENOUS; LETHAL DOSE 50; MICE; MICE, INBRED STRAINS; NANOPARTICLES; PARTICLE SIZE; RATS; RATS, WISTAR; SOLUBILITY; SUSPENSIONS; TOXICITY TESTS;

MUS; RATTUS;

EID: 84871255096     PISSN: 01480545     EISSN: 15256014     Source Type: Journal    
DOI: 10.3109/01480545.2012.710628     Document Type: Article

References (30)

1. Bessin, P., Hauffecheteder, F., Malin, M.-F., Thuillier, J. (1975a). Changes of acute toxicities of digitalis and CIK by administration of a new cardiotropic substance: The (dichloro-2, 3-methoxy 4) phenyl furyl-2 0-(diethylaminoethyl)-ketone-oxime (ANP 4364). Eur J Toxicol 2:122-126
2. Bessin, P., Malin, M.-F., Thuillier, J. (1975b). Potentiation of the acute toxicity of certain antiarrhythmic, psychotropic or cardiotropic substances by prior administration of propranolol in mice (test of cardiotoxicity with propranolol). Eur J Toxicol 3:188-191
3. ChemIDPlus [Internet]. (2009a). Rockville Pike, Bethesda: United states National Library of Medicine; Benzyl alcohol, RN: 100-51-6; 2009 Accessed on: 21 May 2009
4. ChemIDPlus [Internet]. (2009b). Rockville Pike, Bethesda: United states National Library of Medicine; Polysorbate 80, RN: 9005-65-6; 2009 May 12 (cited 2010 August 19). Available at: Http://chem.sis.nlm. nih.gov/chemidplus/ ProxyServlet?objectHandle=DBMaint&actio nHandle=default&nextPage= jsp%2Fchemidlite%2FResultScreen. jsp&responseHandle=JSP&csFldAlias- Alias2=Name&TXTSUPER LISTID=0009005656&CHEMICALNAME= Polysorbate+80&QF1= Name&QO1=%3D&QV1=. Accessed on: 20 May 2009
5. ChemIDPlus [Internet]. (2009c). Rockville Pike, Bethesda: United states National Library of Medicine; Amiodarone, RN: 1951- 25-3; 2009 May 12 (cited 2010 August 19). Available at: Http:// chem.sis.nlm.nih.gov/chemidplus/ ProxyServlet?objectHandle =DBMaint&actionHandle=default&nextPage=jsp/ chemidlite/ ResultScreen.jsp&TXTSUPERLISTID=0001951253. Accessed on: 12 May 2009
6. Cushing, D. J., Kowey, P. R., Cooper, W. D., Massey, B. W., Gralinski, M. W., Lipicky, R. J. (2009). PM101: A cyclodextrin-based intravenous formulation of amiodarone devoid of adverse hemodynamic effects. Eur J Pharm 607:167-172
7. Elhasi, S., Astaneh, R., Lavasanifar, A. (2007). Solubilization of an amphiphilic drug by poly (ethylene oxide)-block-poly(ester) micelles. Eur J.Pharm.Biopharm 65:406-413
8. Gassmann, P., List, M., Schweitzer, A., Sucker, H. (1994). Hydrosols - alternatives for the parenteral application of poorly water soluble drugs. Eur J Pharm Biopharm 40:64-72
9. Goldfrank, L. R. (2006). Goldfrank's toxicologic emergencies, 8th ed. (p. 831). New York: McGraw-Hill
10. Gough, W. B., Zeiler, R. H., Barreca, P., El-Sherif, N. (1982). Hypotensive action of commercial intravenous amiodarone and polysorbate 80 in dogs. J Cardiovasc Pharmacol 4:375-380
11. Kessler, D., Palepu, N., Tustian, A., Rockwell, K., Leo, A., Hughes, M. P., et al. (2002). A novel amiodarone microemulsion injectable formulation. [Abstract]. AAPS Pharm Sci 4:W4122
12. Kipp, J. E., Doty, M. J., Rebbeck, C. L., Eilert, J. Y., inventors; Baxter International, assignee. (2002). Amiodarone-containing parenteral administration. US Patent 6479541
13. Kohn, D. F., Clifford, C. B. (2002). Biology and diseases of rat. In: Fox, J. G., Andersen, L. C., Loew, F. M., Quimbly, F. W. (Eds.), Laboratory animal medicine, 2nd ed. (pp. 121-165). San Diego, California, USA: Academic
14. Llanos L, Moreu R, Peiró AM, Pascual S, Francés R, Such J, Horga JF, Pérez-Mateo M, Zapater P. (2009). Causality assessment of liver injury after chronic oral amiodarone intake. Pharmacoepidemiol Drug Saf 18:291-300
15. Masini, E., Planchenault, J., Pezziardi, F., Gautier, P., Gagnol, J. P. (1985). Histamine-releasing properties of polysorbate 80 in vitro and in vivo: Correlation with its hypotensive action in the dog. Agents Actions 16:470-477
16. Montaguti, P., Melloni, E., Cavelletti, E. (1994). Acute intravenous toxicity of dimethyl sulfoxide, polyethylene glycol 400, dimethylformamide, absolute ethanol, and benzyl alcohol in inbred mouse strains. Drug Res 44:566-570
17. Müller, R. H., Jacobs, C., Kayser, O. (2001). Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future. Adv Drug Deliv Rev 47:3-19
18. Nair, B. (2001). Benzyl alcohol. Cosmetic Ingredient Review. Int J Toxicol 20(Suppl 3):23-50
19. OECD. (2001a). 423 OECD guideline for testing of chemicals, acute oral toxicity - acute toxic class method. 2007 June 10 (cited 2010 August 19). Available at: Http://titania.sourceoecd.org/ vl=25085085/cl=11/nw=1/rpsv/cgi- bin/fulltextew.pl?prpsv=/ij/ oecdjournals/1607310x/v1n4/s23/p1.idx
20. Screening Information Data Set For Benzoates OECD CAS Nos. 65-85-0, 532-32-1, 582-25-2, and 100-51-6 (p. 303). 2008 July 9 (cited 2010 August 19 Available at http://www.chem.unep.ch/. (2011)
21. OECD. (2001b). Screening information data set for benzoates, CAS Nos. 65-85-0, 532-32-1, 582-25-2, and 100-51-6 (p. 303). 2008 July 9 (cited 2010 August 19). Available at: Http://www.chem.unep.ch/irptc/sids/OECDSIDS/sidspub. html. Accessed on: 10 July 2007
22. Prism Pharmaceuticals, Inc. (2008). Nexterone (amiodarone HCl) injection for intravenous use. 2009 January 27 (cited 2010 August 19). Available at: Http://www.accessdata.fda.gov/drugsatfda-docs/label/2008/022325lbl.pdf. Accessed on: 27 January 2009
23. Salgado, H. C., Simões, G. M., Santana Filho, V. J., Dias da Silva, V. J., Salgado, M. C., Fazan, R. (2007). Negative inotropic and lusitropic effects of intravenous amiodarone in conscious rats. Clin Exp Pharmacol Physiol 34:870-887
24. Somberg, J. C., Cvetanovic, I., Ranade, V., Molnar, J. (2004). Comparative effects of rapid bolus administration of aqueous amiodarone versus 10-minute cordarone i.v. infusion on mean arterial blood pressure in conscious dogs. Cardiovasc Drugs Ther 18:345-351
25. Suardi Marinhos, R. F., Bezerra Rodrigues, A. (2008). Occurrence of phlebitis in patients on intravenous amiodarone. Einstein 6:459-462
26. Toxnet, ChemIDPlus [Internet]. (2009). Rockville Pike, Bethesda: United states National Library of Medicine; benzyl alcohol, CASRN: 100-51-6. 2009 May 12 (cited 2010 August 19). Available at: Http://toxnet.nlm.nih.gov/cgi-bin/sis/ search/f?./temp/~j4n6i3:1. Accessed on 20 May 2009
27. Viernstein, H., Stumpf, C. (1992). Similar central actions of intravenous methohexitone suspension and solution in the rabbit. J Pharm Pharmacol 44:66-68
28. Wyeth Laboratories. (2004). Cordarone (amiodarone HCl) tablets, NDA 18-972/S-030. 2009 May 16 (cited 2010 August 19). Available at: Http://www.accessdata.fda.gov/drugsatfda-docs/label/2004/18972s030lbl.pdf. Accessed on: 18 October 2009
29. Yalkowsky, S. H., Krzyzaniak, J. F., Ward, G. H. (1998). Formulationrelated problems associated with intravenous drug delivery. J Pharm Sci 87:787-796
30. Zimetbaum, P. (2007). Amiodarone for atrial fibrillation. N Engl J Med 356:935-941